nilotinib Index

Featured: nilotinib, Tasigna Main Article

Nilotinib (Tasigna) is a kinase inhibitor prescribed for the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia. Side effects, drug interactions, dosing information, and warnings and precautions should be reviewed prior to taking any medication.

Medications

    Related Diseases & Conditions

    • Leukemia Leukemia is a type of cancer of the blood cells in which the growth and development of the blood cells are abnormal. Strictly...learn more »
      In This Article
      Leukemia Article
      • Leukemia facts
      • What is leukemia? What are the different types of leukemia?
      • What causes leukemia? Is leukemia hereditary?
      • What are leukemia risk factors?
      • What are leukemia symptoms and signs?
      • How do physicians diagnose leukemia?
      • What is the treatment for leukemia?
      • What are complications of leukemia?
      • What is the prognosis of leukemia?
      • Is it possible to prevent leukemia?
      • What support groups are available for people with leukemia?
      • What research is being done on leukemia?
    • Cancer Cancer is a disease caused by an abnormal growth of cells, also called malignancy. It is a group of 100 different diseases, and...learn more »
      In This Article
      Cancer Article
      • Cancer facts
      • What is cancer?
      • What causes cancer?
      • What are cancer symptoms and signs?
      • What are the different types of cancer?
      • How is cancer diagnosed?
      • How is cancer staging determined?
      • What is the treatment for cancer?
      • What is the prognosis for cancer?
      • Can cancer be prevented?
      • Where can people find more information about cancer?

Related FAQs, Doctor's & Expert's Views

Health News

FDA Drug Labels on RxList.com


Terms related to nilotinib:

  • Tasigna